Advocates on Steps of Congress 2013
Please leave this field empty
Scleroderma Foundation
Homepage | Forward to a Friend | Make a Donation
20th anniversary Scleroderma Foundation logo 72 dpi banner
eLetter #749 | Feruary 9, 2018  
 DC Capitol Dome Cherry Blossoms portrait

2018 Capitol Hill Day Application

The Capitol Hill Day 2018 application is now available.  Included in the application form is a request for scholarship assistance. An application is required whether you’re applying for a scholarship or not. We need advocates from certain voting districts in California, Florida, Indiana, Kentucky, Louisiana, North Carolina, Oklahoma, Oregon, Tennessee, Vermont, Washington, and West Virginia.   

Deadline to apply (scholarship and non-scholarship) is Wednesday, February 28, 2018. 

Capitol Hill Day 2018 Application

Public Speaking Letter Writing

Grassroots Advocacy Webinar
"Using Your Voice to Meet with an Elected Official"
February 26, 2 p.m. ET

What does a scleroderma advocate do during Capitol Hill Day?  Join our webinar on February 26 at 2 p.m. Eastern time to find out! 

Sit in on a mock meeting that's just like the ones patient advocates have in the offices of Congress members. This small group of advocates will likely include a patient who had undergone stem cell therapy, a parent or caregiver of a child with scleroderma, a patient who uses a medical device and an advocate who works in a chapter. Excellent opportunity to see what the day is all about.

Join Feb. 26 WebinarDial 302-202-5900; 
Enter Conference ID 710-462-255

 2018 Conference Save the Date 180x270 

2018 National Patient Education Conference - July 27-29, Philadelphia

REGISTER ONLINE for the 2018 National Patient Education Conference at If you prefer to register by mail, click here to download a registration form.

Also online are the scholarship application (deadline 3/21) and hotel & travel information

To receive the group room rate of $169, call Loews Philadelphia Hotel, (888) 575-6397, and mention the Scleroderma Foundation conference, or click here to book your room via Loews' online system.

more conference info

 Facebook button

"Facebook Live" from 5th Systemic Sclerosis World Congress

Each person living with scleroderma has a special story.  On February 16 at 11 a.m. Eastern time, the Scleroderma Foundation's Facebook page will share a special "Facebook Live" broadcast from the Systemic Sclerosis World CongressRobert Riggs, CEO of the Scleroderma Foundation, will facilitate an awareness discussion with an international panel of individuals living with scleroderma from Europe and the United States.

 Michigan Chapter Web sized logo

Support Groups

Support groups enable individuals with scleroderma to meet and exchange information with others who face similar problems.  Groups also host speakers on specific on a range of topics from time to time.  

There are many Scleroderma Foundation-affiliated support groups around the country, although some geographic areas are less well represented.  Each week this eLetter will highlight support groups associated with a particular chapter.  The Michigan Chapter hosts eight groups around its state, including one virtual group that meets every other month. 

support groups in Michigan

 Stepping Out Logo Resized

Stepping Out 2018

Help us take one step closer to finding a cure for scleroderma!  Join us at a Stepping Out to Cure Scleroderma walk or run near you.  Gather your family, friends, and coworkers and form a team.  Create a fundraising page on the Stepping Out website and use the online tools to request donations and manage your team. 

Find a Stepping Out walk or run near you at

Clinical Trial Update
CATALYST Trial 2018 300 x 250


If you have scleroderma and PAH (pulmonary arterial hypertension), please visit to learn more about a research study evaluating a once daily oral drug.

learn more

BRAVOS study logo cropBRAVOS study logo


Diffuse cutaneous systemic sclerosis (dcSSc) is an autoimmune disease also known as progressive scleroderma. The BRAVOS clinical trial is currently enrolling scleroderma patients to determine the safety and tolerability of brentuximab vedotin, a drug that is FDA-approved for the treatment of Hodgkin’s and other lymphomas.

The BRAVOS study is being conducted at research centers across the United States. You may be eligible to participate in the BRAVOS study if you:
  • Are 18 to 70 years old
  • Have been diagnosed with dcSSc
  • Have had dcSSc for 5 or fewer years
  • Are on ongoing immunosuppressive therapy with one of the following: methotrexate, mycophenolate mofetil or azathioprine
Learn more about the BRAVOS study on (NCT03222492) or the study website,

Cumberland Pharmaceutical Heart

Research Participation Opportunity

Cumberland Pharmaceuticals is conducting a research study to determine whether a drug product called ifetroban will prevent cardiomyopathy in patients with diffuse scleroderma or pulmonary arterial hypertension associated with scleroderma. Eligible subjects will be reimbursed for their time and travel.

For more information, please call 615-627-4121 or email

Quick Links
Contact Us
Become a Member
About Scleroderma
Calendar of Events
Online Chat
Make a gift
2016 Instagram
Actelion JSN 2018




Disclaimer: The Scleroderma Foundation in no way endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.

Powered by Blackbaud  Unsubscribe | Visit our web site | Contact Us | Donate
300 Rosewood Drive, Suite 105, Danvers, MA 01923 tel: 800-722-HOPE (4673)
© 2018 All rights reserved.